Paul Jeng
Stock Analyst at Guggenheim
(0.11)
# 4,811
Out of 5,133 analysts
37
Total ratings
18.8%
Success rate
-28.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paul Jeng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHRS Coherus Oncology | Reiterated: Buy | $10 → $8 | $0.5255 | +1,422.36% | 3 | Nov 9, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $57 → $52 | $31.83 | +63.37% | 10 | Nov 3, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $35 | $6.62 | +428.70% | 1 | Oct 21, 2026 | |
| ORIC ORIC Pharmaceuticals | Initiated Coverage: Buy | $18 | $7.86 | +129.01% | 1 | Oct 21, 2026 | |
| NBTX Nanobiotix | Reiterated: Buy | $64 | $30.66 | +108.78% | 2 | Sep 25, 2026 | |
| ADAG Adagene | Reiterated: Buy | $10 | $1.71 | +484.80% | 7 | Sep 10, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $45 | $3.39 | +1,227.43% | 2 | Jun 2, 2026 | |
| IMTX Immatics | Reiterated: Buy | $19 | $6.39 | +197.34% | 5 | May 12, 2026 | |
| CNTX Context Therapeutics | Reiterated: Buy | $5 | $0.1808 | +2,665.49% | 4 | May 6, 2026 | |
| IMCR Immunocore Holdings | Initiated Coverage: Hold | n/a | $29.94 | n/a | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $2.53 | n/a | 1 | Jul 29, 2020 |
Coherus Oncology
Nov 9, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $0.5255
Upside: +1,422.36%
IDEAYA Biosciences
Nov 3, 2026
Reiterated: Buy
Price Target: $57 → $52
Current: $31.83
Upside: +63.37%
Kazia Therapeutics
Oct 21, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $6.62
Upside: +428.70%
ORIC Pharmaceuticals
Oct 21, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $7.86
Upside: +129.01%
Nanobiotix
Sep 25, 2026
Reiterated: Buy
Price Target: $64
Current: $30.66
Upside: +108.78%
Adagene
Sep 10, 2026
Reiterated: Buy
Price Target: $10
Current: $1.71
Upside: +484.80%
Corbus Pharmaceuticals Holdings
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $3.39
Upside: +1,227.43%
Immatics
May 12, 2026
Reiterated: Buy
Price Target: $19
Current: $6.39
Upside: +197.34%
Context Therapeutics
May 6, 2026
Reiterated: Buy
Price Target: $5
Current: $0.1808
Upside: +2,665.49%
Immunocore Holdings
Sep 17, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $29.94
Upside: n/a
Jul 29, 2020
Initiated Coverage: Buy
Price Target: $50
Current: $2.53
Upside: n/a